PTC Therapeutics Inc.(PTCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PTCT PTC Therapeutics Inc.

盘后交易 10-10 19:59:40 EDT

66.23

+0.22

+0.33%

盘后62.35

-3.88-5.86%

18:56 EDT

最高67.24	最低65.36	成交量145.56万
今开66.08	昨收66.01	日振幅2.85%
总市值52.61亿	流通市值43.06亿	总股本7,944万
成交额9,651万	换手率2.24%	流通股本6,501万
市净率-25.47	ROE-7740.12%	每股收益7.72
52周最高67.40	52周最低35.51	市盈率8.58
股息0.00	股息收益率0.00	ROA23.81%

北京优虎网络科技有限公司

{"stockData":{"symbol":"PTCT","market":"US","secType":"STK","nameCN":"PTC Therapeutics Inc.","latestPrice":66.23,"timestamp":1760126400000,"preClose":66.01,"halted":0,"volume":1455615,"hourTrading":{"tag":"盘后","latestPrice":62.35,"preClose":66.23,"latestTime":"18:56 EDT","volume":56413,"amount":3735934.5652300003,"timestamp":1760137006755},"delay":0,"floatShares":65010181,"shares":79438094,"eps":7.71893,"marketStatus":"盘后交易","change":0.22,"latestTime":"10-10 19:59:37 EDT","open":66.08,"high":67.24,"low":65.36,"amount":96513417.1953,"amplitude":0.028481,"askPrice":66.09,"askSize":4,"bidPrice":60.99,"bidSize":32,"shortable":3,"etf":0,"ttmEps":7.71893,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1760140800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1371700800000,"exchange":"NASDAQ","adjPreClose":66.01,"preHourTrading":{"tag":"盘前","latestPrice":65.08,"preClose":66.01,"latestTime":"08:59 EDT","volume":10,"amount":655.0600400000001,"timestamp":1760101188376},"postHourTrading":{"tag":"盘后","latestPrice":62.35,"preClose":66.23,"latestTime":"18:56 EDT","volume":56413,"amount":3735934.5652300003,"timestamp":1760137006755},"volumeRatio":1.090298,"impliedVol":0.656,"impliedVolPercentile":0.768},"requestUrl":"/m/hq/s/PTCT","defaultTab":"news","newsList":[{"id":"1174206347","title":"异动解读 | PTC Therapeutics股价盘中大跌6.91%，季度业绩远低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1174206347","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174206347?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:38","pubTimestamp":1754660326,"startTime":"0","endTime":"0","summary":"周五盘中，PTC Therapeutics Inc.股价大跌6.91%，主要原因是该公司公布的季度业绩远低于市场预期。根据公司最新发布的财报，截至6月30日的季度，PTC Therapeutics调整后每股亏损83美分，远高于分析师平均预期的21美分亏损。值得注意的是，尽管公司本季度每股收益为10.04美元，但当季仍亏损6485万美元。这一业绩表现显著低于市场预期，导致投资者信心受挫。尽管如此，华尔街分析师对PTC Therapeutics的12个月目标价中位数仍为64.00美元，较当前股价有约21.3%的上涨空间。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PTCT"],"gpt_icon":0},{"id":"2555503283","title":"PTC Therapeutics盘前涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555503283","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555503283?lang=zh_cn&edition=full","pubTime":"2025-07-29 17:45","pubTimestamp":1753782349,"startTime":"0","endTime":"0","summary":"格隆汇7月29日｜生物制药公司PTC Therapeutics的代谢疾病治疗药物获FDA批准，股价盘前涨超10%。巴克莱银行上调其目标价至46美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072917482497252381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072917482497252381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4576","LU0889565916.HKD","LU0109394709.USD","LU1951200564.SGD","PTC","LU1951198990.SGD","LU2362541273.HKD","BK4139","LU2362540622.SGD","LU2362541513.USD","PTCT","LU0320765992.SGD","LU2506952410.USD","LU2506952337.HKD","BK4588","LENZ","LU1721428347.USD","BK4585","BK4554","BK4007","BK4023","LU2477742899.HKD","LU1923623000.USD","BK4539"],"gpt_icon":0},{"id":"2546126867","title":"基因疗法药物研发商PTC Therapeutics宣布Sephience™获得欧盟委员会批准，治疗患有苯丙酮尿症（PKU）的儿童和成人Sephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)","url":"https://stock-news.laohu8.com/highlight/detail?id=2546126867","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546126867?lang=zh_cn&edition=full","pubTime":"2025-06-25 09:50","pubTimestamp":1750816200,"startTime":"0","endTime":"0","summary":"The marketing authorization is applicable to all 27 European Union member states as well as营销授权适用于所有27个欧盟成员国以及. The Sephience European launch will be initiated in. Sephience 的欧洲上市将在Germany德国in the first half of July.在七月份的上半月。By enhancing the conformational stability of misfolded PAH enzyme and increasing the intracellular concentrations of BH4, Sephience is able to effectively reduce blood Phe levels. Sephience  is approved in the European Economic Area. Sepiapterin is an investigational new drug in .通过增强错误折叠的PAH酶的构象稳定性并增加细胞内BH4的浓度，Sephience能够有效降低血液中的Phe水平。Sephience已在欧洲经济区获批。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625095137978dafae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625095137978dafae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4576","LU2362540622.SGD","LU1951198990.SGD","BK4139","LU0109394709.USD","BK4023","BK4585","PTCT","BK4539","BK4588","BK4554","LU2362541513.USD","LU2506952410.USD","LU2506952337.HKD","PTC","LU1923623000.USD","LU0889565916.HKD","LU2477742899.HKD","LU1951200564.SGD","LU0320765992.SGD","LENZ","BK4007","LU1721428347.USD","LU2362541273.HKD"],"gpt_icon":0},{"id":"2539273845","title":"Uniqure N.V.盘中异动 早盘股价大跌5.00%报14.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539273845","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539273845?lang=zh_cn&edition=full","pubTime":"2025-05-30 22:01","pubTimestamp":1748613668,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日22时01分，Uniqure N.V.股票出现波动，股价快速下跌5.00%。Uniqure N.V.股票所在的生物技术行业中，整体跌幅为4.33%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。消息层面，截至22时01分，《神经科医生看好亨廷顿病将上市疗法 瑞银力挺uniQure潜力》资讯为影响Uniqure N.V.的重要信息。瑞银对 PTC Therapeutics Inc和 uniQure NV均持乐观态度，给予买入评级。该行强调，亨廷顿病领域患者认知度高、治疗意愿强烈，对PTC和uniQure而言均存在巨大机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530220108950854e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530220108950854e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1496350502.SGD","LU1989772923.USD","PTCT","LU0354030438.USD","BK4585","BK4139","LU1162221912.USD","BK4581","BK4533","BK4588","IE00BKVL7J92.USD","LU0943347566.SGD","LU0079474960.USD","LU1093756168.USD","IE00BSNM7G36.USD","BK4083","BK4550","IE00B1XK9C88.USD","LU0823434740.USD","LU1914381329.SGD","LU0942090050.USD","LU0234572021.USD","QURE","LU0868494708.USD","LU1674673428.USD","LU1035775433.USD","LU1778281490.HKD","LU0320765992.SGD","LU1496350171.SGD","BK4504","BK4566","HD","LU1093756325.SGD","LU1551013425.SGD","LU1929549753.HKD","LU1551013342.USD","LU0689472784.USD","LU0320765646.SGD","LU1674673691.USD","LU0820561818.USD","LU0820562030.AUD","LU1069344957.HKD","LU1989772840.SGD","LU2756315664.SGD","LU0823434583.USD","BK4567","IE00BWXC8680.SGD","LU2756315318.SGD","LU0889565916.HKD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2538495406","title":"Uniqure N.V.盘中异动 下午盘急速上涨5.08%报15.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538495406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538495406?lang=zh_cn&edition=full","pubTime":"2025-05-28 01:06","pubTimestamp":1748365569,"startTime":"0","endTime":"0","summary":"北京时间2025年05月28日01时06分，Uniqure N.V.股票出现异动，股价快速上涨5.08%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为1.33%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。消息层面，截至01时06分，《神经科医生看好亨廷顿病将上市疗法 瑞银力挺uniQure潜力》资讯为影响Uniqure N.V.的重要信息。瑞银对 PTC Therapeutics Inc和 uniQure NV均持乐观态度，给予买入评级。该行强调，亨廷顿病领域患者认知度高、治疗意愿强烈，对PTC和uniQure而言均存在巨大机会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505280106109767690f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505280106109767690f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU1551013342.USD","LU1674673428.USD","LU0943347566.SGD","LU1989772840.SGD","IE00BZ1G4Q59.USD","LU1496350171.SGD","LU0320765646.SGD","LU1162221912.USD","BK4581","LU0868494708.USD","IE00BWXC8680.SGD","LU0820561909.HKD","IE00BKVL7J92.USD","LU1674673691.USD","SG9999001440.SGD","LU0868494617.USD","PTCT","LU2756315664.SGD","HD","BK4534","LU0079474960.USD","LU0823434740.USD","IE00B1XK9C88.USD","LU1093756168.USD","LU0109394709.USD","LU0823411888.USD","LU0820561818.USD","LU0354030438.USD","LU0823434583.USD","BK4566","LU1929549753.HKD","IE00BSNM7G36.USD","BK4550","LU0320765992.SGD","QURE","LU0820562030.AUD","BK4083","LU0942090050.USD","LU1778281490.HKD","BK4567","LU1093756325.SGD","BK4504","BK4533","LU1069344957.HKD","LU0354030511.USD","LU1989772923.USD","LU1035775433.USD","BK4585","BK4588"],"gpt_icon":0},{"id":"2538551614","title":"神经科医生看好亨廷顿病将上市疗法 瑞银力挺uniQure(QURE.US)、PTC(PTCT.US)潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2538551614","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538551614?lang=zh_cn&edition=full","pubTime":"2025-05-27 16:50","pubTimestamp":1748335833,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银近日发布生物科技领域研报，神经科医生对uniQure公司的AMT-130和PTC Therapeutics/诺华制药公司的PTC-518在亨廷顿病治疗中的表现十分乐观，若数据积极且疗法明日即可使用，则计划为25%的患者开具AMT-130处方，为40%的患者开具PTC-518处方。医生认为PTC和uniQure的数据前景乐观，并期待PTC在第二季度、uniQure在第三季度更新数据时能展示持续疗效。行业机遇与挑战该行强调，亨廷顿病领域患者认知度高、治疗意愿强烈，对PTC和uniQure而言均存在巨大机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1298049.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4554","LU0320765992.SGD","BK4023","LU1951200564.SGD","BK4139","LU0109394709.USD","LU1951198990.SGD","LU1923623000.USD","BK4585","LU2506952410.USD","LU2506952337.HKD","LU0889565916.HKD","LU2362541513.USD","QURE","PTCT","LU2362541273.HKD","BK4576","LU1721428347.USD","LU2477742899.HKD","BK4588","LU2362540622.SGD","PTC"],"gpt_icon":0},{"id":"2534368212","title":"Ptc Therapeutics, Inc.2025财年第一财季实现净利润8.67亿美元，同比增加1046.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534368212","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534368212?lang=zh_cn&edition=full","pubTime":"2025-05-12 00:01","pubTimestamp":1746979270,"startTime":"0","endTime":"0","summary":"5月12日，Ptc Therapeutics, Inc.公布财报，公告显示公司2025财年第一财季净利润为8.67亿美元，同比增加1046.71%；其中营业收入为11.76亿美元，同比增加460.00%，每股基本收益为11.09美元。从资产负债表来看，Ptc Therapeutics, Inc.总负债28.41亿美元，其中短期债务16.51百万美元，资产负债比为0.94，流动比率为3.90。机构评级：截至2025年5月12日，当前有15家机构对Ptc Therapeutics, Inc.目标价做出预测，其中目标均价为61.13美元，其中最低目标价为40.00美元，最高目标价为112.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512000330a6db2ca2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512000330a6db2ca2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PTCT","LENZ"],"gpt_icon":0},{"id":"1191283153","title":"异动解读 | PTC Therapeutics盘中大涨6.33%，分析师维持\"优于大市\"评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1191283153","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191283153?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:45","pubTimestamp":1746798358,"startTime":"0","endTime":"0","summary":"PTC Therapeutics Inc.今日盘中大涨6.33%，引起投资者广泛关注。该股在交易时段内表现强劲，成交量达到4.1808万股。消息面上，投资银行Baird维持了对PTC Therapeutics的\"优于大市\"评级，尽管将目标价从70.00美元小幅下调至66.00美元。PTC Therapeutics Inc.是一家专注于罕见疾病治疗的生物制药公司。公司致力于发现、开发和商业化临床差异化药物，为患有神经病学和代谢相关罕见疾病的儿童和成人提供创新疗法。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | PTC Therapeutics盘中大涨6.33%，分析师维持\"优于大市\"评级","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PTCT"],"gpt_icon":0},{"id":"1118837059","title":"异动解读 | PTC Therapeutics盘中大涨5.03%，Q1业绩超预期，SUFIANCE商业化前景乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1118837059","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118837059?lang=zh_cn&edition=full","pubTime":"2025-05-09 00:54","pubTimestamp":1746723287,"startTime":"0","endTime":"0","summary":"PTC Therapeutics Inc.今日盘中大涨5.03%，引发市场广泛关注。这一涨幅主要源于公司发布的2025年第一季度财报及未来发展前景。财报显示，PTC Therapeutics第一季度收入达1.9亿美元，其中杜氏肌营养不良业务贡献1.34亿美元，表现强劲。投资者对PTC Therapeutics的新药SUFIANCE在欧洲获得积极意见反应热烈。公司计划在未来12个月内在25个市场推出SUFIANCE，包括德国、美国和日本。尽管Emflaza面临仿制药竞争，但公司表示其品牌忠诚度依然强劲。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | PTC Therapeutics盘中大涨5.03%，Q1业绩超预期，SUFIANCE商业化前景乐观","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PTCT"],"gpt_icon":0},{"id":"2534026151","title":"Ptc Therapeutics, Inc.盘中异动 大幅上涨5.02%报42.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534026151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534026151?lang=zh_cn&edition=full","pubTime":"2025-05-09 00:52","pubTimestamp":1746723168,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日00时52分，Ptc Therapeutics, Inc.股票出现波动，股价快速上涨5.02%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.95%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，致力于发现、开发和商业化临床差异化药物，为患有罕见疾病的儿童和成人带来益处。消息层面，截至00时52分，《Baird：维持PTC Therapeutics评级，由优于大市调整至优于大市评级, 目标价由70.00美元调整至66.00美元。》资讯为影响Ptc Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050900524894f0b78f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050900524894f0b78f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LU0889565916.HKD","PTCT","BK4139","BK4007","LENZ","LU0109394709.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2533952728","title":"Baird：维持PTC Therapeutics评级，由优于大市调整至优于大市评级, 目标价由70.00美元调整至66.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2533952728","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533952728?lang=zh_cn&edition=full","pubTime":"2025-05-08 01:41","pubTimestamp":1746639712,"startTime":"0","endTime":"0","summary":"Baird：维持PTC Therapeutics(PTCT.US)评级，由优于大市调整至优于大市评级, 目标价由70.00美元调整至66.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508014425975231d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508014425975231d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PTCT","PTC","LENZ"],"gpt_icon":0},{"id":"1187259257","title":"异动解读 | PTC Therapeutics盘中大涨8.87%，分析师目标价调整引发投资者关注","url":"https://stock-news.laohu8.com/highlight/detail?id=1187259257","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187259257?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:37","pubTimestamp":1746625052,"startTime":"0","endTime":"0","summary":"周三盘中，PTC Therapeutics股价大幅上涨8.87%，引发市场广泛关注。这一显著涨幅可能与多家投资银行最新发布的研究报告密切相关。据报道，尽管Leerink Partners将PTC Therapeutics的目标价从52美元下调至48美元，但加拿大皇家银行 却将目标价从57美元上调至58美元。这种分歧的观点似乎刺激了市场对PTC Therapeutics股票的需求，导致了盘中的显著上涨。分析师目标价的调整通常会对股价产生重要影响。投资者应密切关注公司未来的业绩表现和行业动态，以评估这一涨势是否可以持续。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PTCT"],"gpt_icon":0},{"id":"2533610936","title":"Ptc Therapeutics, Inc.盘中异动 早盘急速拉升6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533610936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533610936?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:33","pubTimestamp":1746624820,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时33分，Ptc Therapeutics, Inc.股票出现波动，股价大幅拉升6.34%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，致力于发现、开发和商业化临床差异化药物，为患有罕见疾病的儿童和成人带来益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213340a6d66b56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213340a6d66b56&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0109394709.USD","LU0320765992.SGD","LENZ","BK4007","LU0889565916.HKD","PTCT"],"gpt_icon":0},{"id":"1104220401","title":"异动解读 | PTC Therapeutics股价盘前大涨5%，分析师调整目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1104220401","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104220401?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:30","pubTimestamp":1746624646,"startTime":"0","endTime":"0","summary":"PTC Therapeutics周三盘前股价大涨5%，引起投资者关注。这一涨幅可能与多家投资银行最新发布的研究报告有关。据路透社报道，Leerink Partners将PTC Therapeutics的目标价从52美元下调至48美元。与此同时，加拿大皇家银行则将PTC Therapeutics的目标价从57美元上调至58美元，显示出对公司前景的信心。分析师目标价的调整通常会对股价产生影响。这种分歧的观点可能刺激了市场对PTC Therapeutics股票的需求，导致了盘前的显著上涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | PTC Therapeutics股价盘前大涨5%，分析师调整目标价","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PTCT"],"gpt_icon":0},{"id":"2529670687","title":"Ptc Therapeutics, Inc.盘中异动 早盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529670687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529670687?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415108,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分，Ptc Therapeutics, Inc.股票出现波动，股价大幅拉升5.00%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，致力于发现、开发和商业化临床差异化药物，为患有罕见疾病的儿童和成人带来益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213148a6c53c9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213148a6c53c9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","LU0109394709.USD","PTCT","LU0320765992.SGD","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2517334467","title":"PTC Therapeutics(PTCT.US)获Scotiabank首次覆盖，给予与大盘持平评级, 目标价55.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517334467","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517334467?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:42","pubTimestamp":1741387360,"startTime":"0","endTime":"0","summary":"PTC Therapeutics(PTCT.US)获Scotiabank首次覆盖，给予与大盘持平评级, 目标价55.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08064248605342.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PTC","PTCT","LENZ"],"gpt_icon":0},{"id":"2517529624","title":"Ptc Therapeutics, Inc.2024财年实现净利润-3.63亿美元，同比增加42.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517529624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517529624?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363251,"startTime":"0","endTime":"0","summary":"3月8日，Ptc Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-3.63亿美元，同比增加42.11%；其中营业收入为8.07亿美元，同比减少13.97%，每股基本收益为-4.73美元。从资产负债表来看，Ptc Therapeutics, Inc.总负债28.15亿美元，其中短期债务13.36百万美元，资产负债比为0.61，流动比率为2.36。机构评级：截至2025年3月8日，当前有15家机构对Ptc Therapeutics, Inc.目标价做出预测，其中目标均价为62.67美元，其中最低目标价为41.00美元，最高目标价为113.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000221a2647f70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000221a2647f70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PTCT","LENZ"],"gpt_icon":0},{"id":"2516677198","title":"Ptc Therapeutics, Inc.盘中异动 股价大跌5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677198?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:36","pubTimestamp":1741098993,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时36分，Ptc Therapeutics, Inc.股票出现波动，股价大幅跳水5.52%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Exicure, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1082.56%、1072.80%、425.75%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Adma Biologics Inc，振幅分别为23.30%、22.25%、12.57%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，专注于口服小分子疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223634abe7f167&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223634abe7f167&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LENZ","PTCT","LU0109394709.USD","BK4139","LU0320765992.SGD"],"gpt_icon":0},{"id":"2516727371","title":"小摩：维持PTC Therapeutics(PTCT.US)评级，由增持调整至增持评级, 目标价由74.00美元调整至72.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516727371","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516727371?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:45","pubTimestamp":1740761122,"startTime":"0","endTime":"0","summary":"小摩：维持PTC Therapeutics(PTCT.US)评级，由增持调整至增持评级, 目标价由74.00美元调整至72.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/01004548469593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PTC","PTCT","LENZ"],"gpt_icon":0},{"id":"1142137500","title":"PTC Therapeutics 2024年第四季度调整后每股收益$(0.85) 低于预期$(0.66)，销售额$2.13亿 低于预期$2.3244亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1142137500","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142137500?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:18","pubTimestamp":1740691133,"startTime":"0","endTime":"0","summary":"PTC Therapeutics报告季度每股亏损$，低于分析师一致预期的$，差距为28.79%。公司报告季度销售额为$2.13亿美元，低于分析师一致预期的$2.3244亿美元，差距为8.36%。与去年同期的$3.0706亿美元销售额相比，同比下降30.63%。以上内容来自Benzinga Earnings专栏，原文如下：PTC $Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 28.79 percent. This is a 254.17 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $213.00 million which missed the analyst consensus estimate of $232.44 millio","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTCT","PTC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ptcbio.com","stockEarnings":[{"period":"1week","weight":0.0474},{"period":"1month","weight":0.1299},{"period":"3month","weight":0.3596},{"period":"6month","weight":0.5358},{"period":"1year","weight":0.6527},{"period":"ytd","weight":0.4623}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.032},{"period":"3month","weight":0.0762},{"period":"6month","weight":0.257},{"period":"1year","weight":0.1629},{"period":"ytd","weight":0.1452}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ptc Therapeutics, Inc.于1998年3月31日注册成立为一家特拉华州公司。 PTC Therapeutics股份有限公司是一家生物制药公司，专注于用于转录后控制过程中的口服药，专有的小分子药物的发现和开发。同时该公司的研发计划针对于多个治疗领域，公司特别专注于孤儿和超孤儿混乱疾病的治疗的开发和商业化。公司主导的候选产品是ataluren，该产品用于治疗过程中所出现的一种被称为无义突变基因突变的遗传性疾病的治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.100896},{"month":2,"riseRate":0.583333,"avgChangeRate":0.010715},{"month":3,"riseRate":0.416667,"avgChangeRate":-0.07295},{"month":4,"riseRate":0.5,"avgChangeRate":0.024923},{"month":5,"riseRate":0.5,"avgChangeRate":0.022752},{"month":6,"riseRate":0.583333,"avgChangeRate":0.052418},{"month":7,"riseRate":0.666667,"avgChangeRate":0.026829},{"month":8,"riseRate":0.692308,"avgChangeRate":0.062649},{"month":9,"riseRate":0.538462,"avgChangeRate":0.038954},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.077957},{"month":11,"riseRate":0.666667,"avgChangeRate":0.124131},{"month":12,"riseRate":0.666667,"avgChangeRate":0.043806}],"exchange":"NASDAQ","name":"PTC Therapeutics Inc.","nameEN":"PTC Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PTC Therapeutics Inc.(PTCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供PTC Therapeutics Inc.(PTCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"PTC Therapeutics Inc.,PTCT,PTC Therapeutics Inc.股票,PTC Therapeutics Inc.股票老虎,PTC Therapeutics Inc.股票老虎国际,PTC Therapeutics Inc.行情,PTC Therapeutics Inc.股票行情,PTC Therapeutics Inc.股价,PTC Therapeutics Inc.股市,PTC Therapeutics Inc.股票价格,PTC Therapeutics Inc.股票交易,PTC Therapeutics Inc.股票购买,PTC Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PTC Therapeutics Inc.(PTCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供PTC Therapeutics Inc.(PTCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}